srinarao
Posts
-
-
$30 coming soon.
-
Just cant believe how these articles are written. Appears to be very biased to bring the share price down
Recent Opioid Litigation Precedents Have Caused More Uncertainty For Endo $ENDP https://seekingalpha.com/article/4292279
-
Best thing to do is start accumulating
-
Unbelievable how the stock performed today after all the good news it carried after adcomm. Very interesting!
-
Offloaded some today at 4:25. Still holding 30K
-
Added more PM @28.65
-
Could be a tough day tomorrow
-
I would say FDA would take until Jan to sort the labeling/REMS for this product. The product will be likely approved only on its PDUFA date probably a week or two early. That said since the labeling/REMS would need to be implemented by the firm based on FDA’s request, the product will likely be available in Late Feb early March. But this is still the best alternative therapy. Carrying Epipen should not be an issue as these patients always carry them. However, ~60% efficacious in terms of resistance building is a positive outcome. The company is also working on egg allergies. Generic competition are less likely in such products. The company will grow from here.
-
I listened to the entire Adcom. FDA is very interested in approving this product. They were just trying to get more input on what should be part of the REMS. The two negative voters were practicing Physicians. FDA will surely approving this in Jan. I think this will run to $35 in a week, and another $10 after approval + launch of product. Remember this could be potentially be a $1B product peak sales. Let’s hope for the best.
-
Anybody watching AIMT. Got in at $25 Thursday. Potential Peanut allergy approval in Jan 20. Potential $1B revenue. 2.5% of children are suffering from this condition. Likely to open at $30 Monday.
-
BREAKING: Opioid MDL Judge Deserves DQ For Bias, Drug Cos. Say
By Jeff Overley
September 14, 2019, 11:14 AM EDTDrug distributors and pharmacies on Saturday launched a bold attack on the Ohio federal judge supervising multidistrict opioid litigation, accusing him of appearing deeply biased against them and deserving of disqualification....
Does anybody know more about this
-
Law360 Health HEALTH
Friday, September 13, 2019 Follow Health Law360
BREAKING: Sacklers Shifted $1B In Wire Transfers, NY AG Says
The New York attorney general's office said Friday it has uncovered roughly $1 billion in wire transfers made by the Sackler family, owners of Purdue Pharma, in an apparent attempt by the family to shield part of its fortune as it defends itself against a myriad of lawsuits alleging it fueled the opioid crisis. -
Need to be patient i guess.
-
Let’s hope for the best with Purdue settlement terms. Hopefully market takes the terms as positive
-
Need $4.10 at close
-
Added more 3.75
-
Very low volume but still in green
-
$4.52 already in PM. Super!
ENDP
AIMT
ENDP
AIMT
AIMT
ENDP
AIMT
ENDP
AIMT
AIMT
GPOR
ENDP
ENDP
ENDP
ENDP
ENDP
ENDP
ENDP
ENDP
ENDP